/ /

  • linkedin
  • Increase Font
  • Sharebar

    Methamphetamine-associated PAH: First Prospective Cohort Study


    Study limitations include the inability to identify mechanisms underlying Meth-PAH and the potential for confounding as a result of the variety of PAH therapies available during the 12-year period of the study. 


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available